Compare FENC & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | AUDC |
|---|---|---|
| Founded | 1996 | 1992 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 267.0M |
| IPO Year | 2010 | 2000 |
| Metric | FENC | AUDC |
|---|---|---|
| Price | $5.86 | $8.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $15.00 | $12.50 |
| AVG Volume (30 Days) | ★ 206.5K | 80.3K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $69.68 | $4.24 |
| Revenue Next Year | $37.30 | $2.18 |
| P/E Ratio | ★ N/A | $23.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.98 | $6.95 |
| 52 Week High | $9.92 | $11.48 |
| Indicator | FENC | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 59.21 |
| Support Level | $5.65 | $8.78 |
| Resistance Level | $9.16 | $9.19 |
| Average True Range (ATR) | 0.44 | 0.24 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 10.70 | 51.44 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.